{"product_id":"retatrutide-cagrilintide-research-blend","title":"Retatrutide 8 mg + Cagrilintide 2 mg – Dual Peptide Research Blend","description":"\u003ch3 data-section-id=\"1oqfgxx\" data-start=\"0\" data-end=\"93\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Research Overview of Multi-Receptor Metabolic Signaling\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"95\" data-end=\"394\"\u003eCagrilintide and retatrutide are two research peptides studied in relation to metabolic signaling, appetite regulation pathways, and energy balance systems. When examined together in a blend, they interact with complementary receptor networks involved in endocrine signaling and nutrient regulation.\u003c\/p\u003e\n\u003cp data-start=\"396\" data-end=\"705\"\u003eCagrilintide is an amylin analog studied for its interaction with satiety-related signaling pathways and gastrointestinal regulatory systems. Retatrutide is a multi-receptor peptide agonist that interacts with GIP, GLP-1, and glucagon receptor systems associated with metabolic and energy regulation pathways.\u003c\/p\u003e\n\u003cp data-start=\"707\" data-end=\"1189\"\u003eIn research settings, the combination is explored for its role in coordinated receptor signaling and multi-pathway metabolic regulation. Preclinical studies involving these peptide classes have examined their effects on energy intake signaling, metabolic adaptation, and body-composition-related pathways. Clinical investigations involving the individual compounds and related combinations have further expanded understanding of multi-receptor peptide systems in metabolic research.\u003c\/p\u003e\n\u003cp data-start=\"1191\" data-end=\"1339\"\u003eThe blend represents an experimental approach to studying how multiple endocrine pathways interact simultaneously within complex metabolic networks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1j69wd3\" data-start=\"1346\" data-end=\"1437\"\u003e\u003cstrong\u003eCagrilintide + Retatrutide Blend: Molecular Mechanisms of Action at the Molecular Level\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4 data-start=\"1439\" data-end=\"1456\"\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"1458\" data-end=\"1626\"\u003eCagrilintide (AM833\/NN9838) is a long-acting, acylated amylin analog studied as a dual agonist of amylin receptors (AMY1R, AMY2R, AMY3R) and calcitonin receptors (CTR).\u003c\/p\u003e\n\u003cp data-start=\"1628\" data-end=\"1804\"\u003eThese receptors belong to the class B G-protein-coupled receptor (GPCR) family and are formed through interactions between CTR and receptor activity-modifying proteins (RAMPs).\u003c\/p\u003e\n\u003cp data-start=\"1806\" data-end=\"2007\"\u003eAt the molecular level, cagrilintide adopts an α-helical structure stabilized by intramolecular interactions, while lipidation enhances albumin binding and prolongs circulation in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"2009\" data-end=\"2203\"\u003eCryo-EM studies demonstrate a distinctive receptor-binding mode involving both extracellular and transmembrane receptor domains, enabling broad receptor activation across AMYR and CTR complexes.\u003c\/p\u003e\n\u003cp data-start=\"2205\" data-end=\"2395\"\u003eFollowing receptor activation, Gs protein signaling stimulates adenylate cyclase activity, elevates intracellular cyclic AMP (cAMP), and activates downstream protein kinase A (PKA) pathways.\u003c\/p\u003e\n\u003cp data-start=\"2397\" data-end=\"2587\"\u003eThese signaling pathways are studied in relation to neuronal activity within the area postrema (AP), nucleus tractus solitarius (NTS), hypothalamic regions, and peripheral metabolic systems.\u003c\/p\u003e\n\u003ch4 data-start=\"2594\" data-end=\"2610\"\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp data-start=\"2612\" data-end=\"2743\"\u003eRetatrutide (LY3437943) is a multi-receptor peptide agonist built on a glucose-dependent insulinotropic polypeptide (GIP) backbone.\u003c\/p\u003e\n\u003cp data-start=\"2745\" data-end=\"2781\"\u003eIt functions as a triple agonist of:\u003c\/p\u003e\n\u003cp data-start=\"2783\" data-end=\"2922\"\u003e• glucose-dependent insulinotropic polypeptide receptor (GIPR)\u003cbr data-start=\"2845\" data-end=\"2848\"\u003e• glucagon-like peptide-1 receptor (GLP-1R)\u003cbr data-start=\"2891\" data-end=\"2894\"\u003e• glucagon receptor (GCGR)\u003c\/p\u003e\n\u003cp data-start=\"2924\" data-end=\"3093\"\u003eStructural analyses show that retatrutide forms a continuous α-helix interacting with extracellular and transmembrane receptor regions across all three receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3095\" data-end=\"3222\"\u003eThese receptors primarily signal through Gs-mediated cAMP pathways and downstream activation of PKA and ERK signaling cascades.\u003c\/p\u003e\n\u003cp data-start=\"3224\" data-end=\"3483\"\u003eGLP-1R and GIPR activation are studied in relation to glucose-dependent endocrine signaling pathways, while GCGR activation is associated with metabolic signaling related to glycogenolysis, lipid metabolism, and mitochondrial activity in experimental systems.\u003c\/p\u003e\n\u003cp data-start=\"3485\" data-end=\"3617\"\u003eCentral nervous system effects involve hypothalamic and brainstem pathways associated with energy regulation and nutrient signaling.\u003c\/p\u003e\n\u003ch3 data-section-id=\"yn9qpm\" data-start=\"3624\" data-end=\"3671\"\u003e\u003cstrong\u003eCoordinated Signaling and Molecular Synergy\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"3673\" data-end=\"3810\"\u003eIn research models, cagrilintide and retatrutide are studied for their complementary signaling profiles across multiple receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"3812\" data-end=\"3826\"\u003eThese include:\u003c\/p\u003e\n\u003cp data-start=\"3828\" data-end=\"3962\"\u003e• amylin receptor pathways\u003cbr data-start=\"3854\" data-end=\"3857\"\u003e• GLP-1 receptor signaling\u003cbr data-start=\"3883\" data-end=\"3886\"\u003e• GIP receptor pathways\u003cbr data-start=\"3909\" data-end=\"3912\"\u003e• glucagon receptor-mediated metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"3964\" data-end=\"4118\"\u003eThe peptides engage overlapping but distinct neuronal and peripheral systems involved in energy regulation, endocrine signaling, and metabolic adaptation.\u003c\/p\u003e\n\u003cp data-start=\"4120\" data-end=\"4316\"\u003eExperimental findings suggest that simultaneous activation of these pathways may influence coordinated cAMP and PKA signaling across central nervous system nuclei and peripheral metabolic tissues.\u003c\/p\u003e\n\u003cp data-start=\"4318\" data-end=\"4456\"\u003eThe acylated structures of both peptides support prolonged receptor interaction and co-formulation stability in experimental environments.\u003c\/p\u003e\n\u003ch3 data-section-id=\"5xoxpw\" data-start=\"4463\" data-end=\"4496\"\u003e\u003cstrong\u003ePreclinical Research Overview\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"4498\" data-end=\"4678\"\u003ePreclinical studies involving amylin analogs and multi-receptor incretin agonists have examined their effects in animal models related to metabolic signaling and energy regulation.\u003c\/p\u003e\n\u003cp data-start=\"4680\" data-end=\"4710\"\u003eResearch observations include:\u003c\/p\u003e\n\u003cp data-start=\"4712\" data-end=\"4924\"\u003e• modulation of energy intake pathways\u003cbr data-start=\"4750\" data-end=\"4753\"\u003e• alterations in metabolic signaling profiles\u003cbr data-start=\"4798\" data-end=\"4801\"\u003e• changes in lipid and glucose-related pathways\u003cbr data-start=\"4848\" data-end=\"4851\"\u003e• preservation of lean tissue signaling markers in experimental systems\u003c\/p\u003e\n\u003cp data-start=\"4926\" data-end=\"5074\"\u003eStudies involving related peptide combinations further support investigation into coordinated receptor activation and endocrine pathway interaction.\u003c\/p\u003e\n\u003ch3 data-section-id=\"9l10v\" data-start=\"5081\" data-end=\"5110\"\u003e\u003cstrong\u003eClinical Research Context\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5112\" data-end=\"5178\"\u003eClinical research involving the individual compounds has explored:\u003c\/p\u003e\n\u003cp data-start=\"5180\" data-end=\"5317\"\u003e• receptor signaling dynamics\u003cbr data-start=\"5209\" data-end=\"5212\"\u003e• metabolic pathway regulation\u003cbr data-start=\"5242\" data-end=\"5245\"\u003e• endocrine system responses\u003cbr data-start=\"5273\" data-end=\"5276\"\u003e• gastrointestinal signaling mechanisms\u003c\/p\u003e\n\u003cp data-start=\"5319\" data-end=\"5450\"\u003eAdditional investigations continue to examine how multi-receptor peptide systems influence complex metabolic and hormonal networks.\u003c\/p\u003e\n\u003cp data-start=\"5452\" data-end=\"5582\"\u003eAt present, direct combination studies specifically involving cagrilintide and retatrutide remain limited in published literature.\u003c\/p\u003e\n\u003ch3 data-section-id=\"pxh5eu\" data-start=\"5589\" data-end=\"5624\"\u003e\u003cstrong\u003ePotential Research Applications\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"5626\" data-end=\"5774\"\u003eThe molecular signaling characteristics of the cagrilintide + retatrutide blend make it relevant for experimental investigation in areas related to:\u003c\/p\u003e\n\u003cp data-start=\"5776\" data-end=\"5934\"\u003e• metabolic signaling systems\u003cbr data-start=\"5805\" data-end=\"5808\"\u003e• endocrine pathway coordination\u003cbr data-start=\"5840\" data-end=\"5843\"\u003e• gastrointestinal regulatory mechanisms\u003cbr data-start=\"5883\" data-end=\"5886\"\u003e• energy balance and nutrient sensing pathways\u003c\/p\u003e\n\u003cp data-start=\"5936\" data-end=\"6025\"\u003eThese studies are conducted primarily in preclinical and translational research settings.\u003c\/p\u003e\n\u003ch3 data-section-id=\"wv8cei\" data-start=\"6032\" data-end=\"6043\"\u003e\u003cstrong\u003eSummary\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"6045\" data-end=\"6204\"\u003eThe cagrilintide + retatrutide blend is a dual-peptide research formulation studied for its interaction with multiple endocrine and metabolic receptor systems.\u003c\/p\u003e\n\u003cp data-start=\"6206\" data-end=\"6241\"\u003eIts mechanisms are associated with:\u003c\/p\u003e\n\u003cp data-start=\"6243\" data-end=\"6421\"\u003e• amylin receptor signaling\u003cbr data-start=\"6270\" data-end=\"6273\"\u003e• GLP-1, GIP, and glucagon receptor activation\u003cbr data-start=\"6319\" data-end=\"6322\"\u003e• cAMP-mediated intracellular pathways\u003cbr data-start=\"6360\" data-end=\"6363\"\u003e• coordinated central and peripheral metabolic signaling\u003c\/p\u003e\n\u003cp data-start=\"6423\" data-end=\"6581\"\u003eAs a research formulation, this blend is explored to better understand how multi-receptor peptide systems influence complex biological and metabolic networks.\u003c\/p\u003e\n\u003cp data-start=\"6588\" data-end=\"6727\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eAll information presented is based on experimental and clinical research data and is intended for scientific and educational purposes only.\u003c\/p\u003e","brand":"PRG","offers":[{"title":"Pre-filled Pen","offer_id":53000814133514,"sku":null,"price":285.0,"currency_code":"EUR","in_stock":true},{"title":"Vial","offer_id":53000814166282,"sku":null,"price":260.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0908\/7113\/6522\/files\/Cagrilintide_Retatrutide.png?v=1778074379","url":"https:\/\/www.peptideregenesis.com\/products\/retatrutide-cagrilintide-research-blend","provider":"PRG","version":"1.0","type":"link"}